811 Ranolazine reduces Trastuzumab toxicity in vitro and in vivo, when it is administered after anticancer treatment. (September 2015) - Maurea, N.; Coppola, C.; Piscopo, G.; Galletta, F.; Esposito, E.; Capasso, I.; Arra, C.; Riccio, G.; Lorenzo, C. De; Laurentiis, M. De